🎉 #UniSR celebrates two winners of the first #ERCPoC 2026: Prof. Matteo Iannacone and Dr. Alessandra Boletta.
#LiveRNA will advance mRNA-based immunotherapies for liver cancer, while #QrCiliopathies will drive new therapies for polycystic kidney disease.
@erc.europa.eu
#LiveRNA will advance mRNA-based immunotherapies for liver cancer, while #QrCiliopathies will drive new therapies for polycystic kidney disease.
@erc.europa.eu
June 30, 2026 at 12:34 PM
🎉 #UniSR celebrates two winners of the first #ERCPoC 2026: Prof. Matteo Iannacone and Dr. Alessandra Boletta.
#LiveRNA will advance mRNA-based immunotherapies for liver cancer, while #QrCiliopathies will drive new therapies for polycystic kidney disease.
@erc.europa.eu
#LiveRNA will advance mRNA-based immunotherapies for liver cancer, while #QrCiliopathies will drive new therapies for polycystic kidney disease.
@erc.europa.eu
Exciting news😀LiveRNA, co-founded by @iannaconelab.bsky.social, has been selected for the BOOST Grant from the Paris-Saclay Cancer Cluster. The award will accelerate the development of a next-generation #mRNA #immunotherapy platform, advancing innovative cancer treatments toward the clinic.
July 8, 2026 at 10:02 AM
Exciting news😀LiveRNA, co-founded by @iannaconelab.bsky.social, has been selected for the BOOST Grant from the Paris-Saclay Cancer Cluster. The award will accelerate the development of a next-generation #mRNA #immunotherapy platform, advancing innovative cancer treatments toward the clinic.
🧵(3/3) Continued investment in high-quality research is positive news for the PKD community, and we look forward to following the progress of this important project.
Read more: www.hsr.it/news/2026/gi...
#PKDInternational #PKD #Research
Read more: www.hsr.it/news/2026/gi...
#PKDInternational #PKD #Research
2 progetti di ricerca del San Raffaele tra i vincitori dell’ERC Proof of Concept 2026
I progetti di ricerca QrCiliopathies su malattia renale policistica e LiveRNA su tumore al fegato, sviluppati da Boletta e Iannacone dell'IRCCS San Raffaele, vincono l'ERC Proof of Concept 2026.<br/>
www.hsr.it
July 8, 2026 at 2:17 PM
🧵(3/3) Continued investment in high-quality research is positive news for the PKD community, and we look forward to following the progress of this important project.
Read more: www.hsr.it/news/2026/gi...
#PKDInternational #PKD #Research
Read more: www.hsr.it/news/2026/gi...
#PKDInternational #PKD #Research
LiveRNA lauréat i-Lab 2026 ! Bravo ! et hâte de poursuivre notre partenariat. Très excitant et de superbe perspectives
curie.fr/actualite/le...
curie.fr/actualite/le...
Le projet de société LiveRNA, lauréat i-Lab 2026 : vers la 35e start-up issue de l’Institut Curie - Institut Curie
Retrouvez Le projet de société LiveRNA, lauréat i-Lab 2026 : vers la 35e start-up issue de l’Institut Curie. L'Institut Curie est le 1er centre de recherche et de lutte contre le cancer en France.
curie.fr
September 21, 2026 at 6:14 AM
LiveRNA lauréat i-Lab 2026 ! Bravo ! et hâte de poursuivre notre partenariat. Très excitant et de superbe perspectives
curie.fr/actualite/le...
curie.fr/actualite/le...
November 18, 2024 at 1:33 AM
🧵(2/3) 🔬 This grant recognises the strength of their research and will support the next steps in translating scientific findings into potential therapeutic applications.
2 progetti di ricerca del San Raffaele tra i vincitori dell’ERC Proof of Concept 2026
I progetti di ricerca QrCiliopathies su malattia renale policistica e LiveRNA su tumore al fegato, sviluppati da Boletta e Iannacone dell'IRCCS San Raffaele, vincono l'ERC Proof of Concept 2026.<br/>
www.hsr.it
July 8, 2026 at 2:17 PM
🧵(2/3) 🔬 This grant recognises the strength of their research and will support the next steps in translating scientific findings into potential therapeutic applications.
Sir liverna kovbasa
November 19, 2024 at 4:49 PM
Sir liverna kovbasa